114 related articles for article (PubMed ID: 14558738)
1. Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG).
Khan S; Javaid A; Ghori RA; Mahmood K; Anwer N; Khan SU; Iqbal ZH; Rahman F; Ullah S; Imran K; Akhter N; Khan MK; Siddqui SJ; Fareed A; Khan MH
J Pak Med Assoc; 2003 Aug; 53(8):338-45. PubMed ID: 14558738
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
3. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
[TBL] [Abstract][Full Text] [Related]
4. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
5. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Busman TA; Norris S; Notario GF
Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
[TBL] [Abstract][Full Text] [Related]
6. An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis.
Weiss K; Vanjaka A;
Clin Ther; 2002 Dec; 24(12):2105-22. PubMed ID: 12581548
[TBL] [Abstract][Full Text] [Related]
7. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
Alanis A; Longest KA; Senetar JE; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
[TBL] [Abstract][Full Text] [Related]
8. Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis.
Wettengel R; Vetter N; Waardenburg FA
J Antimicrob Chemother; 1993 Jun; 31(6):963-72. PubMed ID: 8360133
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis.
Haczyński J; Chyczewska E; Grzelewska-Rzymowska I; Malolepszy J; Marcinkowska-Suchowierska E; Milanowski J; Oklek K; Płusa T; Słominski J; Szmygin K; Rek M
Med Sci Monit; 2002 Jan; 8(1):PI1-7. PubMed ID: 11782685
[TBL] [Abstract][Full Text] [Related]
10. Clarithromycin and cefaclor suspensions in the treatment of acute otitis media in children.
Gooch WM; Gan VN; Corder WT; Khurana CM; Andrews WP
Pediatr Infect Dis J; 1993 Dec; 12(12 Suppl 3):S128-33. PubMed ID: 8295814
[TBL] [Abstract][Full Text] [Related]
11. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
Weiss LR
Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
[TBL] [Abstract][Full Text] [Related]
12. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
[TBL] [Abstract][Full Text] [Related]
13. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
Wilson R; Schentag JJ; Ball P; Mandell L;
Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
[TBL] [Abstract][Full Text] [Related]
14. Five days of cefprozil versus 10 days of clarithromycin in the treatment of an acute exacerbation of chronic bronchitis.
McCarty JM; Pierce PF
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):327-34. PubMed ID: 11686426
[TBL] [Abstract][Full Text] [Related]
15. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
16. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis.
Adler JL; Jannetti W; Schneider D; Zhang J; Palmer R; Notario G
Clin Ther; 2000 Dec; 22(12):1410-20. PubMed ID: 11192133
[TBL] [Abstract][Full Text] [Related]
17. Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion.
Tagaya E; Tamaoki J; Kondo M; Nagai A
Chest; 2002 Jul; 122(1):213-8. PubMed ID: 12114361
[TBL] [Abstract][Full Text] [Related]
18. Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study.
Swanson RN; Lainez-Ventosilla A; De Salvo MC; Dunne MW; Amsden GW
Treat Respir Med; 2005; 4(1):31-9. PubMed ID: 15725048
[TBL] [Abstract][Full Text] [Related]
19. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Gotfried MH; Ellison WT
Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
